Cargando…
Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis
SIMPLE SUMMARY: Ewing Sarcoma is a rare cancer that, when localized, has an overall five-year survival rate of 70%. Patients with metastasis have a five-year survival rate of 15 to 30%. Early analysis of patient prognosis can be crucial to provide adequate treatment and increase chances of survival....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070584/ https://www.ncbi.nlm.nih.gov/pubmed/33924679 http://dx.doi.org/10.3390/cancers13081860 |
_version_ | 1783683504295378944 |
---|---|
author | Ribeiro-Dantas, Marcel da Câmara Imparato, Danilo Oliveira Dalmolin, Matheus Gibeke Siqueira de Farias, Caroline Brunetto Brunetto, André Tesainer da Cunha Jaeger, Mariane Roesler, Rafael Sinigaglia, Marialva Siqueira Dalmolin, Rodrigo Juliani |
author_facet | Ribeiro-Dantas, Marcel da Câmara Imparato, Danilo Oliveira Dalmolin, Matheus Gibeke Siqueira de Farias, Caroline Brunetto Brunetto, André Tesainer da Cunha Jaeger, Mariane Roesler, Rafael Sinigaglia, Marialva Siqueira Dalmolin, Rodrigo Juliani |
author_sort | Ribeiro-Dantas, Marcel da Câmara |
collection | PubMed |
description | SIMPLE SUMMARY: Ewing Sarcoma is a rare cancer that, when localized, has an overall five-year survival rate of 70%. Patients with metastasis have a five-year survival rate of 15 to 30%. Early analysis of patient prognosis can be crucial to provide adequate treatment and increase chances of survival. Besides, it is a disease with several gaps in our understanding, including regulation of genes and which transcription factors are master regulators. This work addresses these two topics by inferring gene regulatory networks that allow us to identify putative master regulators to predict patient prognosis. We were able to identify two sets of master regulators that can predict good and bad patient outcomes. ABSTRACT: Ewing Sarcoma (ES) is a rare malignant tumor occurring most frequently in adolescents and young adults. The ES hallmark is a chromosomal translocation between the chromosomes 11 and 22 that results in an aberrant transcription factor (TF) through the fusion of genes from the FET and ETS families, commonly EWSR1 and FLI1. The regulatory mechanisms behind the ES transcriptional alterations remain poorly understood. Here, we reconstruct the ES regulatory network using public available transcriptional data. Seven TFs were identified as potential MRs and clustered into two groups: one composed by PAX7 and RUNX3, and another composed by ARNT2, CREB3L1, GLI3, MEF2C, and PBX3. The MRs within each cluster act as reciprocal agonists regarding the regulation of shared genes, regulon activity, and implications in clinical outcome, while the clusters counteract each other. The regulons of all the seven MRs were differentially methylated. PAX7 and RUNX3 regulon activity were associated with good prognosis while ARNT2, CREB3L1, GLI3, and PBX3 were associated with bad prognosis. PAX7 and RUNX3 appear as highly expressed in ES biopsies and ES cell lines. This work contributes to the understanding of the ES regulome, identifying candidate MRs, analyzing their methilome and pointing to potential prognostic factors. |
format | Online Article Text |
id | pubmed-8070584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80705842021-04-26 Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis Ribeiro-Dantas, Marcel da Câmara Imparato, Danilo Oliveira Dalmolin, Matheus Gibeke Siqueira de Farias, Caroline Brunetto Brunetto, André Tesainer da Cunha Jaeger, Mariane Roesler, Rafael Sinigaglia, Marialva Siqueira Dalmolin, Rodrigo Juliani Cancers (Basel) Article SIMPLE SUMMARY: Ewing Sarcoma is a rare cancer that, when localized, has an overall five-year survival rate of 70%. Patients with metastasis have a five-year survival rate of 15 to 30%. Early analysis of patient prognosis can be crucial to provide adequate treatment and increase chances of survival. Besides, it is a disease with several gaps in our understanding, including regulation of genes and which transcription factors are master regulators. This work addresses these two topics by inferring gene regulatory networks that allow us to identify putative master regulators to predict patient prognosis. We were able to identify two sets of master regulators that can predict good and bad patient outcomes. ABSTRACT: Ewing Sarcoma (ES) is a rare malignant tumor occurring most frequently in adolescents and young adults. The ES hallmark is a chromosomal translocation between the chromosomes 11 and 22 that results in an aberrant transcription factor (TF) through the fusion of genes from the FET and ETS families, commonly EWSR1 and FLI1. The regulatory mechanisms behind the ES transcriptional alterations remain poorly understood. Here, we reconstruct the ES regulatory network using public available transcriptional data. Seven TFs were identified as potential MRs and clustered into two groups: one composed by PAX7 and RUNX3, and another composed by ARNT2, CREB3L1, GLI3, MEF2C, and PBX3. The MRs within each cluster act as reciprocal agonists regarding the regulation of shared genes, regulon activity, and implications in clinical outcome, while the clusters counteract each other. The regulons of all the seven MRs were differentially methylated. PAX7 and RUNX3 regulon activity were associated with good prognosis while ARNT2, CREB3L1, GLI3, and PBX3 were associated with bad prognosis. PAX7 and RUNX3 appear as highly expressed in ES biopsies and ES cell lines. This work contributes to the understanding of the ES regulome, identifying candidate MRs, analyzing their methilome and pointing to potential prognostic factors. MDPI 2021-04-13 /pmc/articles/PMC8070584/ /pubmed/33924679 http://dx.doi.org/10.3390/cancers13081860 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ribeiro-Dantas, Marcel da Câmara Imparato, Danilo Oliveira Dalmolin, Matheus Gibeke Siqueira de Farias, Caroline Brunetto Brunetto, André Tesainer da Cunha Jaeger, Mariane Roesler, Rafael Sinigaglia, Marialva Siqueira Dalmolin, Rodrigo Juliani Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis |
title | Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis |
title_full | Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis |
title_fullStr | Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis |
title_full_unstemmed | Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis |
title_short | Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis |
title_sort | reverse engineering of ewing sarcoma regulatory network uncovers pax7 and runx3 as master regulators associated with good prognosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070584/ https://www.ncbi.nlm.nih.gov/pubmed/33924679 http://dx.doi.org/10.3390/cancers13081860 |
work_keys_str_mv | AT ribeirodantasmarceldacamara reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT imparatodanilooliveira reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT dalmolinmatheusgibekesiqueira reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT defariascarolinebrunetto reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT brunettoandretesainer reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT dacunhajaegermariane reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT roeslerrafael reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT sinigagliamarialva reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis AT siqueiradalmolinrodrigojuliani reverseengineeringofewingsarcomaregulatorynetworkuncoverspax7andrunx3asmasterregulatorsassociatedwithgoodprognosis |